Skip to content
Rolling·Ingested 45 days ago, not re-verified since. Deadlines can change; confirm on the official page.

6515--MagPro R30 Transcranial Magnetic Stimulation (TMS) Equipment

VETERANS AFFAIRS, DEPARTMENT OF

Presolicitation · not yet biddable. There is nothing to bid on yet: agencies use this notice type for market research or information. You can respond to get on their radar, but do not budget proposal time for it.

Place of performance: Las Vegas, NV

View official posting

Free. Verify your email, then we send one reminder only.

Posted
Jul 17, 2026
Closes
Rolling, no fixed deadline

See more open contract opportunities like this

Get alerted when new contract opportunities like this open.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

At a glance

This is a government contract opportunity posted by VETERANS AFFAIRS, DEPARTMENT OF in the electromedical and electrotherapeutic apparatus manufacturing category. Applications are accepted on a rolling basis. Work is performed in Las Vegas, NV.

Classification and identifiers

Industry (NAICS)
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
Product or service (PSC)
Medical and Surgical Instruments, Equipment, and Supplies (6515)
Solicitation number
36C26126Q0590
Contracting office
261-NETWORK CONTRACT OFFICE 21 (36C261)

Who can apply

Work performed in Las Vegas, NV

About this opportunity

PRE-SOLICITATION NOTICE OF INTENT TO SOLE SOURCE Department of Veterans Affairs (VA) Network Contracting Office (NCO 21) intends to award a sole source, firm fixed price contract to MagVenture, Inc. for MagPro R30 Transcranial Magnetic Stimulation & Applicable Accessories. The procurement is on behalf of the Department of Veterans Affairs, Veterans Health Administration, Regional Procurement Office West (RPOW), Network Contracting Office (NCO) 21, on behalf of Southern Nevada Health Care System. Based on the market research conducted, the MagPro R30 TMS System is the only TMS system found to be FDA approved for the treatment of Pain (stimulation of peripheral nerves), Major Depressive Disorder (MDD), MDD with Anxiety, MDD as an adjunct treatment for adolescents aged 15-21, and adjunct trea...

Refine this search